Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer
CA 2420051 A1 · Owner: The University Of Bristol · Inventors: Dawbarn, David; Allen, Shelley Jane
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to the treatment of cancer and is particularly though , not exclusively concerned with the treatment of pancreatic cancer. In particular the invention related to the use of TrkAlg2 in the preparation of a medicament for the treatment and/or prevention of cancer in a patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.